{
 "metadata": {
  "name": "",
  "signature": "sha256:f1028ba99b9bb949c87983653188f01a9c1ad55efefda31c8ebb961cf2c63a77"
 },
 "nbformat": 3,
 "nbformat_minor": 0,
 "worksheets": [
  {
   "cells": [
    {
     "cell_type": "heading",
     "level": 2,
     "metadata": {},
     "source": [
      "Deep semantic choices for job 716173 with positive and speculative combined into one choice"
     ]
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "2015-04-22 Tong Shu Li"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import pandas as pd\n",
      "import matplotlib.pyplot as plt\n",
      "\n",
      "%matplotlib inline\n",
      "%pylab inline"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Populating the interactive namespace from numpy and matplotlib\n"
       ]
      }
     ],
     "prompt_number": 1
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "from itertools import islice\n",
      "from collections import Counter"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 2
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import sys\n",
      "sys.path.append(\"/home/toby/crowdsourcing/drug_disease_semantics/src/\")\n",
      "\n",
      "from filter_data import filter_data\n",
      "from true_relation_type import get_euadr_relation_type\n",
      "from aggregate_results import aggregate_results\n",
      "from aggregate_votes import aggregate_votes\n",
      "from get_orig_problem import get_orig_problem"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 3
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "sys.path.append(\"/home/toby/global_util/\")\n",
      "from file_util import read_file"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 4
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Read our data:"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "settings = {\n",
      "    \"loc\": \"/home/toby/crowdsourcing/drug_disease_semantics/data/\",\n",
      "    \"fname\": \"job_716713_full_with_untrusted_and_unfinished.tsv\",\n",
      "    \"data_subset\": \"normal\",\n",
      "    \"min_accuracy\": 0.7,\n",
      "    \"max_accuracy\": 1.0,\n",
      "    \"id_column\": \"pub_rel_id\",\n",
      "    \"categories\": [[\"positive\", \"speculative\"], [\"negative\"], [\"false\"]]\n",
      "}"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 5
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "raw_data = filter_data(settings)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 7
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "euadr_answer = get_euadr_relation_type(settings)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 8
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(raw_data)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 9,
       "text": [
        "1022"
       ]
      }
     ],
     "prompt_number": 9
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def create_match(gold_std_answer):\n",
      "    def match(identifier, crowd_choice):\n",
      "        return int(crowd_choice == gold_std_answer[identifier])\n",
      "    \n",
      "    return match"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 10
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "match_obj = create_match(euadr_answer)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 11
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "results = aggregate_results(\"pub_rel_id\", \"broad_rel_type\", raw_data, match_obj)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 12
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Look at the results:"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def determine_matches(results):\n",
      "    matches = []\n",
      "    mismatches = []\n",
      "    for rel_id, group in results.groupby(\"pub_rel_id\"):\n",
      "        if group.iloc[0][\"match\"] == 1:\n",
      "            matches.append(rel_id)\n",
      "        else:\n",
      "            mismatches.append(rel_id)\n",
      "            \n",
      "    return (matches, mismatches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 13
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "matches, mismatches = determine_matches(results)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 14
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(matches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 15,
       "text": [
        "173"
       ]
      }
     ],
     "prompt_number": 15
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(mismatches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 16,
       "text": [
        "71"
       ]
      }
     ],
     "prompt_number": 16
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def deep_sem_summary(work_units):\n",
      "    temp = []\n",
      "    for rel_id in work_units:\n",
      "        subset = results.query(\"pub_rel_id == '{0}'\".format(rel_id))\n",
      "        top_choice = subset.iloc[0][\"broad_rel_type\"]\n",
      "        \n",
      "        if top_choice not in [\"false\", \"negative\"]:\n",
      "            raw_subset = raw_data.query(\"pub_rel_id == '{0}'\".format(rel_id))\n",
      "\n",
      "            top_subset = raw_subset.query(\"broad_rel_type == '{0}'\".format(top_choice))\n",
      "\n",
      "            ans = aggregate_votes(\"deep_semantics\", top_subset)\n",
      "            \n",
      "            total_vote_score = sum(ans[\"conf_score\"])\n",
      "            percent_agree = ans[\"conf_score\"] / total_vote_score\n",
      "            \n",
      "            ans[\"percent_agree\"] = percent_agree\n",
      "            ans.insert(0, \"pub_rel_id\", rel_id)\n",
      "            \n",
      "            ans = ans.sort([\"conf_score\"], ascending = False)\n",
      "            \n",
      "            temp.append(ans)\n",
      "            \n",
      "    return pd.concat(temp)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 19
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "deep_sem_res = deep_sem_summary(matches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 20
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "loc = \"/home/toby/crowdsourcing/drug_disease_semantics/data/\"\n",
      "\n",
      "pub_to_raw_mapping = dict()\n",
      "for line in islice(read_file(loc + \"raw_to_toby_mapping.txt\"), 1, None):\n",
      "    pub_rel_id, raw_rel_id, num_agree = line.split('|')\n",
      "    pub_to_raw_mapping[pub_rel_id] = (raw_rel_id, int(num_agree))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 21
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "orig_problem = get_orig_problem(\"pub_rel_id\", raw_data)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 22
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def summary(work_units):\n",
      "    for identifier in work_units:\n",
      "        subset = results.query(\"pub_rel_id == '{0}'\".format(identifier))\n",
      "        \n",
      "        unit_id = raw_data.query(\"pub_rel_id == '{0}'\".format(identifier)).iloc[0][\"_unit_id\"]\n",
      "        \n",
      "        deep_subset = deep_sem_res.query(\"pub_rel_id == '{0}'\".format(identifier))\n",
      "        \n",
      "        print \"Unit id: {0}\".format(unit_id)\n",
      "        print\n",
      "        print \"EU-ADR answer:\", euadr_answer[identifier]\n",
      "        print \"Experts agree: {0}/3\".format(pub_to_raw_mapping[identifier][1])\n",
      "        print\n",
      "        print subset\n",
      "        print\n",
      "        if not deep_subset.empty:\n",
      "            print deep_subset\n",
      "            print\n",
      "        print orig_problem[identifier][3]\n",
      "        print\n",
      "        print \"============================================================\""
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 23
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "summary(matches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124714\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id        broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_0  positive_speculative      2.5589          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_0      may_cause      2.5589          3              1\n",
        "\n",
        "Body height, weight and obesity increase the risk of [[venous thrombosis]], especially obesity in women using [[oral contraceptives]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124715\n",
        "\n",
        "EU-ADR answer: false\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_10          false      4.2055          5       0.845378      1\n",
        "1  drug_disease_10       negative      0.7692          1       0.154622      0\n",
        "\n",
        "ET-1 mRNA expression was significantly higher in patients with [[CsA]]-induced gingival overgrowth (P <0.001) than in patients with [[periodontitis]] and the controls.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124805\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_100  positive_speculative      4.3753          5   \n",
        "0  drug_disease_100                 false      1.7333          2   \n",
        "1  drug_disease_100              negative      1.5025          2   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.574858      1  \n",
        "0       0.227733      0  \n",
        "1       0.197409      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_100  used_to_treat      4.3753          5              1\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and [[itraconazole]] in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124787\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_101  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_101      may_cause      2.3788          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, [[nausea]], vomiting, and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124869\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_102  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_102      may_cause      2.5879          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, nausea, [[vomiting]], and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124848"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_103  positive_speculative      4.3053          5   \n",
        "0  drug_disease_103                 false      0.8462          1   \n",
        "1  drug_disease_103              negative      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.731597      1  \n",
        "0       0.143794      0  \n",
        "1       0.124609      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_103  used_to_treat      4.3053          5              1\n",
        "\n",
        "Similarly, the same regimen of [[posaconazole]] reduced invasive fungal infections (95% CI -9.7 to -2.5) and [[aspergillosis]] (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124890\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_104  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_104  used_to_treat      2.6092          3              1\n",
        "\n",
        "Similarly, the same regimen of [[posaconazole]] reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706985414\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_105  positive_speculative      2.4421          3   \n",
        "0  drug_disease_105              negative      0.8333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.745588      1  \n",
        "0       0.254412      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_105      may_cause      2.4421          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include [[headache]], fever, nausea, vomiting, and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124875\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_106  positive_speculative      6.6010          8   \n",
        "0  drug_disease_106              negative      0.7857          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.893633      1  \n",
        "0       0.106367      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_106  used_to_treat      5.0071          6       0.758537\n",
        "1  drug_disease_106          other      0.8571          1       0.129844\n",
        "0  drug_disease_106      may_cause      0.7368          1       0.111619\n",
        "\n",
        "At this time, [[posaconazole]] should probably be reserved for prophylaxis in patients at high risk for [[invasive fungal infection]], as salvage therapy in refractory or resistant infections, or for patients with intolerance to other therapies.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124750\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_107  positive_speculative      3.4032          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_107  used_to_treat      3.4032          4              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "At this time, [[posaconazole]] should probably be reserved for prophylaxis in patients at high risk for invasive fungal infection, as salvage therapy in refractory or [[resistant infections]], or for patients with intolerance to other therapies.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124686\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_108  positive_speculative      5.3364          6   \n",
        "0  drug_disease_108                 false      1.7091          2   \n",
        "1  drug_disease_108              negative      0.7692          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.682867      1  \n",
        "0       0.218703      0  \n",
        "1       0.098430      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_108  used_to_treat      4.4133          5       0.827018\n",
        "0  drug_disease_108      may_cause      0.9231          1       0.172982\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with [[fluconazole]] and itraconazole in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124756\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_11  positive_speculative      1.9091          2   \n",
        "0  drug_disease_11              negative      0.8333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.696142      1  \n",
        "0       0.303858      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_11      may_cause      1.9091          2              1\n",
        "\n",
        "ET-1 mRNA expression was significantly higher in patients with [[CsA]]-induced [[gingival overgrowth]] (P <0.001) than in patients with periodontitis and the controls.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124830\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_110  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_110  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_110          other      0.7273          1       0.305742\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and [[aspergillosis]] incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124775\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_111  positive_speculative      2.5901          3   \n",
        "0  drug_disease_111                 false      0.8000          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.764019      1  \n",
        "0       0.235981      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_111  used_to_treat      2.5901          3              1\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124885"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_112  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_112  used_to_treat      2.5879          3              1\n",
        "\n",
        "Posaconazole is noninferior to [[fluconazole]] for treatment of [[oropharyngeal candidiasis]] (95% CI -6.6 to 5.0), but necessity for this indication remains unclear, as many other treatment options exist.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124821\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_113  positive_speculative      2.4848          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_113  used_to_treat      1.6515          2       0.664641\n",
        "0  drug_disease_113      may_cause      0.8333          1       0.335359\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124679\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_114  positive_speculative      4.6257          5   \n",
        "0  drug_disease_114                 false      3.4956          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.569576      1  \n",
        "0       0.430424      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_114  used_to_treat      3.7026          4       0.800441\n",
        "0  drug_disease_114      may_cause      0.9231          1       0.199559\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and [[aspergillosis]] incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124917\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_115  positive_speculative      7.3867          9   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_115      may_cause      4.0131          5       0.543287\n",
        "1  drug_disease_115  used_to_treat      3.3736          4       0.456713\n",
        "\n",
        "While some beneficial neuromotor effects of succimer therapy were observed in the present study there remains several unanswered questions such as how long these effects will persist and how [[succimer]] therapy modifies lead-associated [[cerebellar deficits]] manifesting as perturbations in vestibular and/or proprioception systems for postural balance and functional locomotion.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706989513\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_117  positive_speculative      3.3022          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_117      may_cause      3.3022          4              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "It is well known that [[tobacco smoke]] exposure is related to the risk of developing [[cardiovascular diseases]] and events.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124836\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_118  positive_speculative      2.4745          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_118  used_to_treat      2.4745          3              1\n",
        "\n",
        "[[Tibolone]] is a selective tissue estrogenic activity regulator, approved for the treatment of [[vasomotor symptoms]] in postmenopausal women.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124687\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_12  positive_speculative      5.0693          6   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_12      may_cause      5.0693          6              1\n",
        "\n",
        "These results suggest that CsA can modulate the expression of ET-1 in gingival fibroblasts and [[CsA]]-induced [[gingival overgrowth]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124702\n",
        "\n",
        "EU-ADR answer: negative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_126       negative       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of [[vascular lesions]] during the two years an [[etonogestrel]] implant was used by diabetic women.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124694\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_127  positive_speculative      6.8545          8   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_127  used_to_treat      6.8545          8              1\n",
        "\n",
        "[[Oritavancin]]: a new promising agent in the treatment of [[infections due to Gram-positive pathogens]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124772\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_128  positive_speculative      3.2931          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_128      may_cause      3.2931          4              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Our findings support that ecstasy use, or [[ecstasy/cannabis]] synergic effects, are responsible for the sub-clinical deficits observed in ecstasy polydrug users, and provides additional evidence for [[long-term cognitive impairment]] owing to ecstasy consumption in the context of polydrug use.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707282367\n",
        "\n",
        "EU-ADR answer: false\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_13          false      2.3596          3              1      1\n",
        "\n",
        "Gingival samples were collected from eight normal healthy individuals, eight patients with [[periodontitis]], and eight patients with cyclosporin A ([[CsA]])-induced gingival overgrowth.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124785\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_136  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_136      may_cause      2.5078          3              1\n",
        "\n",
        "Adverse events were similar across treatment groups except for higher rates of [[anemia]] in the groups receiving [[ribavirin]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124764\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_137  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_137  used_to_treat      2.5078          3              1\n",
        "\n",
        "Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with [[chronic hepatitis C genotype 4]] treated with peginterferon plus [[ribavirin]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124877\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_139  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_139      may_cause      2.4833          3              1\n",
        "\n",
        "For exposure levels within standard recommended guidelines, [[radioisotopes]] are far more likely to play a role in the occurrence of [[spontaneous abortions]] than X-rays.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124688\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_14  positive_speculative      2.4221          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_14      may_cause      2.4221          3              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Gingival samples were collected from eight normal healthy individuals, eight patients with periodontitis, and eight patients with [[cyclosporin A]] (CsA)-induced [[gingival overgrowth]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124719\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_141  positive_speculative      2.6754          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_141  used_to_treat      1.8421          2       0.688533\n",
        "0  drug_disease_141      may_cause      0.8333          1       0.311467\n",
        "\n",
        "An open multicenter phase II trial of weekly [[docetaxel]] for [[advanced-stage non-small-cell lung cancer]] in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124882\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_142  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_142      may_cause      2.4148          3              1\n",
        "\n",
        "Contrarily, [[LABA]] showed a significant increase in [[asthma-related deaths]] (Relative Risk=3.83; 95% CI, 1.21-12.14).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124765\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_144  positive_speculative      2.4245          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_144  used_to_treat      2.4245          3              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of [[high-dose cyclophosphamide]] 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124812\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_145  positive_speculative      2.5873          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_145  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_145      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, [[adriamycin]] 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124829\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_146  positive_speculative      2.5598          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_146  used_to_treat      2.5598          3              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, [[cisplatin]], cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124820\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_147  positive_speculative      2.5873          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_147  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_147      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and [[prednisone]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124744\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_148  positive_speculative      5.2119          6   \n",
        "0  drug_disease_148                 false      1.7564          2   \n",
        "1  drug_disease_148              negative      0.7692          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.673590      1  \n",
        "0       0.226998      0  \n",
        "1       0.099412      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_148  used_to_treat      5.2119          6              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, [[vincristine]] and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124770\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_149  positive_speculative      4.1183          5   \n",
        "0  drug_disease_149                 false      0.8182          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.834255      1  \n",
        "0       0.165745      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_149  used_to_treat      4.1183          5              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, [[cytarabine]] and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124768\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_15  positive_speculative      5.6485          7   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_15  used_to_treat      5.6485          7              1\n",
        "\n",
        "The evidence suggests that [[montelukast]] is an effective monotherapy controller in children with [[mild asthma]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707287260"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_150  positive_speculative        2.85          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_150  used_to_treat        2.85          3              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of [[etoposide]], cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124740\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_151  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_151  used_to_treat      1.6278          2       0.679099\n",
        "0  drug_disease_151      may_cause      0.7692          1       0.320901\n",
        "\n",
        "Plasma [[ziprasidone]] levels ranged from 20 ng/mL to 160 ng/mL (mean: 75.8 ng/mL) and were significantly related to the improvement in [[negative symptoms]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124683\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_153  positive_speculative      2.6322          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_153      may_cause      2.6322          3              1\n",
        "\n",
        "Characteristic features of an [[inflammation]] induced by [[bevacizumab]] injection include an early onset with painless loss in VA mostly without conjunctival or ciliary injection.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124794\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_154  positive_speculative      2.4745          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_154  used_to_treat      1.6745          2       0.676702\n",
        "0  drug_disease_154      may_cause      0.8000          1       0.323298\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/[[prednisone]]) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124919\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_155  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_155  used_to_treat      2.5879          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP ([[rituximab]]/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124759\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_156  positive_speculative      2.6209          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_156  used_to_treat      2.6209          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/[[doxorubicin]]/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124776\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_157  positive_speculative      2.3778          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_157  used_to_treat      2.3778          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/[[cyclophosphamide]]/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124786\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_158  positive_speculative      2.6744          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_158  used_to_treat      2.6744          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/[[vincristine]]/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124858\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_159  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_159      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_159  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and [[lung cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124881\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_160  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_160      may_cause      2.3596          3              1\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of [[melanoma]], non-Hodgkin's lymphoma, and lung cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707218352"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_161  positive_speculative      2.5421          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_161      may_cause      2.5421          3              1\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, [[non-Hodgkin's lymphoma]], and lung cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124795\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_163  positive_speculative      2.5873          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_163      may_cause      2.5873          3              1\n",
        "\n",
        "There was an estimated 50% excess risk of malignancy among [[methotrexate]]-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in [[non-Hodgkin's lymphoma]] (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124757\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_164  positive_speculative      2.5971          3   \n",
        "0  drug_disease_164                 false      0.8333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.757084      1  \n",
        "0       0.242916      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_164      may_cause      2.5971          3              1\n",
        "\n",
        "There was an estimated 50% excess risk of malignancy among [[methotrexate]]-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in [[lung cancer]] (SIR 2.9, 95% CI 1.6-4.8).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124835\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_165  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_165      may_cause      2.5078          3              1\n",
        "\n",
        "There was an estimated 50% excess risk of malignancy among [[methotrexate]]-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in [[melanoma]] (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124852\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_166  positive_speculative      2.5598          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_166  used_to_treat      2.5598          3              1\n",
        "\n",
        "Incidence of melanoma and other malignancies among [[rheumatoid arthritis]] patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124894"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_167  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_167  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_167      may_cause      0.8333          1       0.310516\n",
        "\n",
        "To determine cancer risk in a cohort of 459 [[rheumatoid arthritis]] (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124912\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_168  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_168  used_to_treat      0.8571          1       0.354936\n",
        "0  drug_disease_168      may_cause      0.8077          1       0.334479\n",
        "1  drug_disease_168          other      0.7500          1       0.310585\n",
        "\n",
        "To determine [[cancer]] risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124828\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_169  positive_speculative      2.5666          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_169      may_cause      1.7666          2       0.688304\n",
        "1  drug_disease_169  used_to_treat      0.8000          1       0.311696\n",
        "\n",
        "Incidence of melanoma and other [[malignancies]] among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124721\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_170  positive_speculative      2.4892          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_170      may_cause      1.6559          2       0.665234\n",
        "1  drug_disease_170  used_to_treat      0.8333          1       0.334766\n",
        "\n",
        "Incidence of [[melanoma]] and other malignancies among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124803\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_172  positive_speculative      2.5666          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_172      may_cause      2.5666          3              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Absence of villin predisposes mice to [[dextran sodium sulfate]]-induced [[colitis]] by promoting apoptosis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124816\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_175  positive_speculative      3.3668          4   \n",
        "0  drug_disease_175                 false      0.8000          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.808006      1  \n",
        "0       0.191994      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_175      may_cause      3.3668          4              1\n",
        "\n",
        "Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral anticoagulant and instituting [[heparin]] therapy prior to the planned dental procedure, which can result in [[thromboembolism]] and increased morbidity and mortality.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124727\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_176  positive_speculative      2.4221          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_176  used_to_treat      2.4221          3              1\n",
        "\n",
        "Finally, in non-small cell lung cancer (NSCLC) in patients' progressing on chemotherapy [[sutent]] was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for [[lung cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124793\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_177  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_177  used_to_treat      2.5078          3              1\n",
        "\n",
        "In several phase I/II/III studies, [[sutent]] was found to be effective as second and first line treatment in [[metastatic renal cell carcinoma]] (RCC).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124911\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_178  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_178  used_to_treat      2.5879          3              1\n",
        "\n",
        "Finally, in non-small cell lung cancer ([[NSCLC]]) in patients' progressing on chemotherapy [[sutent]] was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for lung cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124763\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_179  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_179  used_to_treat       2.397          3              1\n",
        "\n",
        "[[Sutent]] was also effective as second line treatment in patients with gastrointestinal stromal tumors ([[GIST]]) with 8% response rate, 70% stable disease and a 20-month median survival.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124737\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_180  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_180  used_to_treat       2.397          3              1\n",
        "\n",
        "In addition, a phase II study in multitreated women with [[breast cancer]], [[sutent]] demonstrated a moderate activity with 16% clinical benefit.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124739\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_181  positive_speculative      2.6039          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_181  used_to_treat      2.6039          3              1\n",
        "\n",
        "[[Epoetin beta]] effectively increases hemoglobin levels, reduces the need for transfusions and improves the quality of life in patients with symptomatic chemotherapy-induced [[anemia]] with a range of solid tumors and lymphoid malignancies.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124761\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_184  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_184  used_to_treat       2.397          3              1\n",
        "\n",
        "During the induction phase, tacrolimus or cyclosporine, [[mycophenolate mofetil]], and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124907\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_185  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_185  used_to_treat       2.609          3              1\n",
        "\n",
        "During the induction phase, [[tacrolimus]] or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124902"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_186  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_186  used_to_treat      2.5879          3              1\n",
        "\n",
        "During the induction phase, tacrolimus or cyclosporine, mycophenolate mofetil, and [[methylprednisolone]] were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124758\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_187  positive_speculative      2.7424          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_187  used_to_treat      2.7424          3              1\n",
        "\n",
        "During the induction phase, tacrolimus or [[cyclosporine]], mycophenolate mofetil, and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124797\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_188  positive_speculative      2.5598          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_188      may_cause      2.5598          3              1\n",
        "\n",
        "The most frequent and the most troublesome adverse effect of [[interferon]] plus ribavirin-based therapy is [[anaemia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124709\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_189  positive_speculative      2.4892          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_189      may_cause      2.4892          3              1\n",
        "\n",
        "In multivariate analysis the risk of [[anaemia]] was significantly associated with [[zidovudine]] (OR, 3.27 95% CI, 1.64-6.54, P = 0.0008) and peg-IFN (OR, 2.35; 95% CI, 1.16-4.57, P = 0.0179).\n",
        "\n",
        "============================================================\n",
        "Unit id: 707284912\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_19  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_19  used_to_treat      2.4833          3              1\n",
        "\n",
        "The results from these studies, encompassing end points measuring lung function and symptoms, found that [[montelukast]] provided effective and beneficial [[asthma]] control to children aged 2 to 14 years with mild asthma.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124680"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_190  positive_speculative      6.2663          7   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_190      may_cause      4.6330          5       0.739352\n",
        "1  drug_disease_190          other      0.8333          1       0.132981\n",
        "2  drug_disease_190  used_to_treat      0.8000          1       0.127667\n",
        "\n",
        "[[Zidovudine]] discontinuation could help to avoid [[anaemia]] associated with anti-HCV therapy.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124742\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_191  positive_speculative      3.3201          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_191  used_to_treat      2.5509          3        0.76832\n",
        "0  drug_disease_191      may_cause      0.7692          1        0.23168\n",
        "\n",
        "The risk of [[anaemia]] was lower in patients with higher baseline haemoglobin levels (OR, 0.35 95% CI, 0.26-0.49, P < 0.0001) and in patients receiving [[protease inhibitor]]-based antiretroviral therapy (OR, 0.51 95% CI, 0.30-0.86, P = 0.0114).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124716\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_192  positive_speculative      2.4221          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_192      may_cause      1.6948          2       0.699723\n",
        "1  drug_disease_192  used_to_treat      0.7273          1       0.300277\n",
        "\n",
        "The most frequent and the most troublesome adverse effect of interferon plus [[ribavirin]]-based therapy is [[anaemia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124732\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_193  positive_speculative      2.4004          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_193  used_to_treat      2.4004          3              1\n",
        "\n",
        "This study demonstrated that both low-dose topiramate and [[propranolol]] could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707280277\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_194  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_194  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_194      may_cause      0.8571          1       0.331195"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "This study demonstrated that both low-dose [[topiramate]] and propranolol could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124916\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_195  positive_speculative      2.5483          3   \n",
        "0  drug_disease_195                 false      0.8077          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.759327      1  \n",
        "0       0.240673      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_195  used_to_treat      2.5483          3              1\n",
        "\n",
        "Results - The [[topiramate]] group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, [[headache]] intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124710\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_196  positive_speculative      1.8517          2   \n",
        "0  drug_disease_196              negative      0.7692          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.706513      1  \n",
        "0       0.293487      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_196  used_to_treat      1.8517          2              1\n",
        "\n",
        "Results - The [[topiramate]] group showed a reduction in the mean (+/-SD) of monthly [[migraine]] frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124825\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_197  positive_speculative      2.5666          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_197      may_cause      2.5666          3              1\n",
        "\n",
        "Long-term exposure to [[medium-dose glucocorticoid]] therapy associates with [[hypertension]] in patients with rheumatoid arthritis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124883\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_20  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_20  used_to_treat      2.6092          3              1\n",
        "\n",
        "This article reviewed recent results from randomized, double-blind studies of children with mild asthma treated with [[montelukast]], a leukotriene receptor antagonist that is approved for the treatment of asthma and [[allergic rhinitis]] in children and adults.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124796\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_201  positive_speculative      3.2931          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_201  used_to_treat      3.2931          4              1\n",
        "\n",
        "Collectively, the cardiovascular benefit, metabolic neutrality and homogeneous blood pressure response illuminated in recent studies, and reviewed here, represent a reaffirmation of the benefit of [[long-acting dihydropyridine calcium channel antagonists]] and should serve to help reinforce the critical importance of these agents in the therapeutic armamentarium against [[cardiovascular disease]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124844\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_204  positive_speculative      3.4821          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_204  used_to_treat      3.4821          4              1\n",
        "\n",
        "Compared with both diuretics and contemporary agents, [[amlodipine]] decreases [[cardiovascular events]] to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124678\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_206  positive_speculative      4.1178          5   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_206  used_to_treat      4.1178          5              1\n",
        "\n",
        "All three patients had recurrent admissions for stomal bleeding and [[stomal varices secondary to portal hypertension]] and were initially treated with local measures (pressure, [[silver nitrate]], and suture ligation).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124774\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_207  positive_speculative      2.4867          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_207  used_to_treat      2.4867          3              1\n",
        "\n",
        "All three patients had recurrent admissions for [[stomal bleeding]] and stomal varices secondary to portal hypertension and were initially treated with local measures (pressure, [[silver nitrate]], and suture ligation).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124855\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_208  positive_speculative      4.9656          6   \n",
        "0  drug_disease_208                 false      1.6333          2   \n",
        "1  drug_disease_208              negative      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.677232      1  \n",
        "0       0.222757      0  \n",
        "1       0.100011      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_208  used_to_treat      4.9656          6              1\n",
        "\n",
        "At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did [[allopurinol]] (300 or 100 mg) or placebo in subjects with hyperuricemia and [[gout]], including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124863"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_209  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_209  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_209      may_cause      0.8571          1       0.331195\n",
        "\n",
        "At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did [[allopurinol]] (300 or 100 mg) or placebo in subjects with [[hyperuricemia]] and gout, including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124811\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_21  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_21  used_to_treat      2.3788          3              1\n",
        "\n",
        "The combination of high-dose MTX with [[procarbazine]] and CCNU is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124748\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_210  positive_speculative      2.5845          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_210  used_to_treat      2.5845          3              1\n",
        "\n",
        "A significantly (P < 0.05) higher percentage of subjects with [[impaired renal function]] treated with [[febuxostat]] 80 mg (4 [44%] of 9), 120 mg (5 [45%] of 11), and 240 mg (3 [60%] of 5) achieved the primary end point compared with those treated with 100 mg of allopurinol (0 [0%] of 10).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124831\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_211  positive_speculative      3.3181          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_211      may_cause      1.6666          2       0.502275\n",
        "2  drug_disease_211  used_to_treat      0.8333          1       0.251138\n",
        "1  drug_disease_211          other      0.8182          1       0.246587\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with febuxostat than with [[allopurinol]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124730\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_212  positive_speculative      2.4221          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_212  used_to_treat      2.4221          3              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and [[gout]], including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124856\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_213  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_213  used_to_treat      1.5577          2       0.645064\n",
        "0  drug_disease_213          other      0.8571          1       0.354936\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately [[impaired renal function]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124789\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_214  positive_speculative      2.5598          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_214  used_to_treat      2.5598          3              1\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with [[hyperuricemia]] and gout, including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124723\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_215  positive_speculative      5.2462          6   \n",
        "1  drug_disease_215              negative      1.5549          2   \n",
        "0  drug_disease_215                 false      0.8000          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.690190      1  \n",
        "1       0.204562      0  \n",
        "0       0.105248      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_215  used_to_treat      5.2462          6              1\n",
        "\n",
        "A significantly (P < 0.05) higher percentage of subjects with [[impaired renal function]] treated with febuxostat 80 mg (4 [44%] of 9), 120 mg (5 [45%] of 11), and 240 mg (3 [60%] of 5) achieved the primary end point compared with those treated with 100 mg of [[allopurinol]] (0 [0%] of 10).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124815\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_216  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_216      may_cause      1.7745          2       0.707592\n",
        "1  drug_disease_216  used_to_treat      0.7333          1       0.292408\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with [[febuxostat]] than with allopurinol.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124906\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_217  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_217      may_cause      2.4833          3              1\n",
        "\n",
        "Proportions of subjects experiencing any adverse event or serious adverse event were similar across groups, although diarrhea and [[dizziness]] were more frequent in the [[febuxostat]] 240 mg group.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124814\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_218  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_218      may_cause      2.5078          3              1\n",
        "\n",
        "Proportions of subjects experiencing any adverse event or serious adverse event were similar across groups, although [[diarrhea]] and dizziness were more frequent in the [[febuxostat]] 240 mg group.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706694486\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_22  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_22  used_to_treat      1.6071          2       0.665521\n",
        "0  drug_disease_22      may_cause      0.8077          1       0.334479\n",
        "\n",
        "The combination of [[high-dose MTX]] with procarbazine and CCNU is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124728\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_220  positive_speculative      2.4221          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_220      may_cause      2.4221          3              1\n",
        "\n",
        "While the association between [[neural tube defects]] and [[antiepileptic drugs]] is well recognised, other congenital malformations are known to occur.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124767\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_221  positive_speculative      6.0411          7   \n",
        "0  drug_disease_221                 false      1.6182          2   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.788727      1  \n",
        "0       0.211273      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_221      may_cause      6.0411          7              1\n",
        "\n",
        "While the association between neural tube defects and [[antiepileptic drugs]] is well recognised, other [[congenital malformations]] are known to occur.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124712"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_223  positive_speculative      3.3201          4   \n",
        "0  drug_disease_223                 false      3.2879          4   \n",
        "1  drug_disease_223              negative      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.452250      1  \n",
        "0       0.447863      0  \n",
        "1       0.099887      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_223      may_cause      2.5928          3        0.78094\n",
        "1  drug_disease_223          other      0.7273          1        0.21906\n",
        "\n",
        "Data of our study revealed an unexpected high rate of hypogonadism irrespective of [[cyclophosphamide]] use, and subclinical involvement of the testes by the [[vasculitis]] itself might be an alternative explanation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124871\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_224  positive_speculative        2.85          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_224  used_to_treat        2.85          3              1\n",
        "\n",
        "The patient was on corticosteroids and [[azathioprine]] for [[autoimmune hepatitis]] at the time of her presentation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124734\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_225  positive_speculative      2.5589          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_225      may_cause      1.6498          2        0.64473\n",
        "1  drug_disease_225          other      0.9091          1        0.35527\n",
        "\n",
        "[[Pulmonary alveolar proteinosis]]: a rare pulmonary toxicity of [[sirolimus]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707276727\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_226  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_226      may_cause      2.4148          3              1\n",
        "\n",
        "[[PAP]] is a very rare complication of [[SRL]] therapy with only a few cases described.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124837\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_23  positive_speculative      2.3778          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_23  used_to_treat      2.3778          3              1\n",
        "\n",
        "The combination of high-dose MTX with procarbazine and [[CCNU]] is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283394"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_230  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_230      may_cause      2.4148          3              1\n",
        "\n",
        "All patients converted to SRL because of [[GI side effects]] of [[MMF]] showed improvements, and none of those converted because of hyperglycemia experienced improvement.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124879\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_231  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_231  used_to_treat      1.7333          2       0.697983\n",
        "0  drug_disease_231      may_cause      0.7500          1       0.302017\n",
        "\n",
        "We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of [[severe diarrhea]] due to [[MMF]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707780960\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_234  positive_speculative      2.8611          3   \n",
        "0  drug_disease_234              negative      0.9333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.754032      1  \n",
        "0       0.245968      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_234      may_cause      2.8611          3              1\n",
        "\n",
        "Moreover, [[oxcarbazepine]] can be a valid choice when long-term therapy is required because of the low interaction with other drugs and the low [[hematological side effects]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124779\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_236  positive_speculative      2.5598          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_236  used_to_treat      2.5598          3              1\n",
        "\n",
        "Our data showed that [[oxcarbazepine]] can be a good alternative to traditional antiepileptic agents in the prevention of [[perioperative seizures]] being efficacy, ease of use (rapid titration in 3 days, not requiring close plasma concentration monitoring) and good tolerability (no major side effects during titration and during the first postoperative week) the key factors.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124784\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_238  positive_speculative      2.4745          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_238  used_to_treat      2.4745          3              1\n",
        "\n",
        "We tested the hypothesis that [[oral beclomethasone dipropionate]] (BDP) would control gastrointestinal graft-versus-host disease ([[GVHD]]) in patients with anorexia, vomiting, and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124804"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_24  positive_speculative      2.5901          3   \n",
        "0  drug_disease_24                 false      0.8000          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.764019      1  \n",
        "0       0.235981      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_24  used_to_treat      2.5901          3              1\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124895\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_240  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_240  used_to_treat      1.8398          2       0.705174\n",
        "0  drug_disease_240      may_cause      0.7692          1       0.294826\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of [[prednisone]]; survival is statistically significantly better among patients receiving BDP.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124840\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_241  positive_speculative      2.4848          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_241  used_to_treat      2.4848          3              1\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of prednisone; survival is statistically significantly better among patients receiving [[BDP]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124736\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_242  positive_speculative      2.4004          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_242      may_cause      2.4004          3              1\n",
        "\n",
        "Grade 3 or 4 leukopenia and [[edema]] and various grade 1 or 2 adverse events were more frequent in patients receiving eight [[TAC]] cycles than in those receiving six cycles.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124697\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_243  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_243      may_cause       2.397          3              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Grade 3 or 4 [[leukopenia]] and edema and various grade 1 or 2 adverse events were more frequent in patients receiving eight [[TAC]] cycles than in those receiving six cycles.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124874\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_25  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_25  used_to_treat      1.8015          2       0.690442\n",
        "0  drug_disease_25      may_cause      0.8077          1       0.309558\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as [[intravenous meperidine]] and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124846\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_26  positive_speculative      1.7594          2   \n",
        "0  drug_disease_26                 false      0.7273          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.707524      1  \n",
        "0       0.292476      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_26  used_to_treat      0.9412          1       0.534955\n",
        "0  drug_disease_26          other      0.8182          1       0.465045\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124798\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_27  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_27  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_27          other      0.7273          1       0.305742\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124870\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_28  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_28  used_to_treat       2.609          3              1\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as [[intravenous meperidine]] and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124726\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_29  positive_speculative      2.5971          3   \n",
        "0  drug_disease_29                 false      0.8333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.757084      1  \n",
        "0       0.242916      0  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_29  used_to_treat      1.6559          2       0.637596\n",
        "0  drug_disease_29      may_cause      0.9412          1       0.362404\n",
        "\n",
        "Mean [[pain]] (mm) recorded before injection, before reduction, and after reduction in the [[intra-articular lidocaine]] group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124698\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_30  positive_speculative      2.4686          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_30  used_to_treat      1.6504          2       0.668557\n",
        "0  drug_disease_30      may_cause      0.8182          1       0.331443\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124910\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_32  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_32  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_32      may_cause      0.8333          1       0.310516\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124706\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_33  positive_speculative      7.3413          9   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_33  used_to_treat      5.5849          7       0.760751\n",
        "1  drug_disease_33          other      0.9231          1       0.125741\n",
        "0  drug_disease_33      may_cause      0.8333          1       0.113509\n",
        "\n",
        "Selective cytotoxicity of [[indomethacin]] and indomethacin ethyl ester-loaded nanocapsules against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124735\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_34  positive_speculative      2.7424          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_34  used_to_treat      2.7424          3              1\n",
        "\n",
        "The main finding of the present study is that [[indomethacin-loaded nanocapsules]] formulation was more potent than a solution of indomethacin in decreasing the viability and cell proliferation of [[glioma]] lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124713"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_35  positive_speculative      3.3312          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_35  used_to_treat      3.3312          4              1\n",
        "\n",
        "The main finding of the present study is that indomethacin-loaded nanocapsules formulation was more potent than a [[solution of indomethacin]] in decreasing the viability and cell proliferation of [[glioma]] lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124889\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_36  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_36  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_36      may_cause      0.8333          1       0.310516\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124806\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_38  positive_speculative      2.4245          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_38  used_to_treat      0.9412          1       0.388204\n",
        "0  drug_disease_38      may_cause      0.7500          1       0.309342\n",
        "1  drug_disease_38          other      0.7333          1       0.302454\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124771\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_39  positive_speculative      4.1544          5   \n",
        "1  drug_disease_39              negative      2.5743          3   \n",
        "0  drug_disease_39                 false      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.556741      1  \n",
        "1       0.344988      0  \n",
        "0       0.098271      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_39  used_to_treat      1.6904          2       0.406894\n",
        "1  drug_disease_39          other      1.6515          2       0.397530\n",
        "0  drug_disease_39      may_cause      0.8125          1       0.195576\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124724\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_40  positive_speculative      6.6163          8   \n",
        "0  drug_disease_40                 false      0.8235          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.889312      1  \n",
        "0       0.110688      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_40  used_to_treat      4.2113          5       0.636504\n",
        "0  drug_disease_40      may_cause      1.4606          2       0.220758\n",
        "1  drug_disease_40          other      0.9444          1       0.142738"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Further investigations using in vivo [[glioma]] model should be helpful to confirm the distinct effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]], in normal versus tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124876\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_41  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_41          other      1.0000          1       0.402690\n",
        "2  drug_disease_41  used_to_treat      0.7500          1       0.302017\n",
        "0  drug_disease_41      may_cause      0.7333          1       0.295293\n",
        "\n",
        "The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]] on [[glioma]] cell lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124733\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_42  positive_speculative      2.4892          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_42  used_to_treat      1.6559          2       0.665234\n",
        "0  drug_disease_42      may_cause      0.8333          1       0.334766\n",
        "\n",
        "Indomethacin and [[indomethacin ethyl ester]] associated together in the same nanocapsule formulation caused a synergic effect decreasing [[glioma]] cell proliferation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124884\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_43  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_43  used_to_treat      2.3596          3              1\n",
        "\n",
        "[[Indomethacin]] and indomethacin ethyl ester associated together in the same nanocapsule formulation caused a synergic effect decreasing [[glioma]] cell proliferation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124868\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_45  positive_speculative      6.3885          8   \n",
        "0  drug_disease_45              negative      0.8182          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.886467      1  \n",
        "0       0.113533      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_45  used_to_treat      4.0851          5       0.639446\n",
        "0  drug_disease_45      may_cause      2.3034          3       0.360554\n",
        "\n",
        "Further investigations using in vivo [[glioma]] model should be helpful to confirm the distinct effects of [[indomethacin-loaded nanocapsules]] and indomethacin ethyl ester-loaded nanocapsules, in normal versus tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124773\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_46  positive_speculative      2.5245          3   \n",
        "0  drug_disease_46                 false      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.774909      1  \n",
        "0       0.225091      0  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_46  used_to_treat      2.5245          3              1\n",
        "\n",
        "Quantification of circulating varicella-zoster virus DNA for follow-up in a case of [[visceral varicella-zoster infection]] ameliorated with [[intravenous acyclovir]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124853\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_47  positive_speculative      2.3778          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_47  used_to_treat      2.3778          3              1\n",
        "\n",
        "We describe a patient with acute lymphocytic leukemia (ALL) who developed [[visceral varicella-zoster virus]] (VZV) infection following cord blood stem cell transplantation (CBSCT) and was successfully treated with [[intravenous acyclovir]] (ACV).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124807\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_48  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_48  used_to_treat      2.5078          3              1\n",
        "\n",
        "We describe a patient with acute lymphocytic leukemia (ALL) who developed visceral varicella-zoster virus ([[VZV) infection]] following cord blood stem cell transplantation (CBSCT) and was successfully treated with [[intravenous acyclovir]] (ACV).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124693\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_49  positive_speculative      7.5666          9   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_49  used_to_treat      6.7666          8       0.894272\n",
        "0  drug_disease_49      may_cause      0.8000          1       0.105728\n",
        "\n",
        "Available studies in the literature using clozapine in the pediatric population are summarized and the NIMH experience in treating [[refractory childhood-onset schizophrenia]] cases with [[clozapine]] is discussed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124704\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id        broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_5  positive_speculative       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_5      may_cause       2.397          3              1\n",
        "\n",
        "However, decreased tear production after [[botulinum toxin]] injection for crow's feet is a possible complication and patients should be advised of the small but definite risk of a temporary [[dry eye]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124707"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_50  positive_speculative      2.4004          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_50  used_to_treat      1.6504          2       0.687552\n",
        "0  drug_disease_50      may_cause      0.7500          1       0.312448\n",
        "\n",
        "Although the role of [[clozapine]] is well established for [[treatment-resistant schizophrenia]], it is rarely used in pediatric populations, mainly due to its potentially serious adverse effects.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124893\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_51  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_51  used_to_treat      2.3596          3              1\n",
        "\n",
        "To summarize practical aspects of use of [[clozapine]] in treating children with [[schizophrenia]] and management of associated adverse effects.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124747\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_52  positive_speculative      3.4655          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_52  used_to_treat      3.4655          4              1\n",
        "\n",
        "Despite a higher incidence of adverse effects in children, [[clozapine]] appears to be a uniquely beneficial second-line agent for treating children with [[refractory schizophrenia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124854\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_53  positive_speculative      2.5598          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_53      may_cause      2.5598          3              1\n",
        "\n",
        "[[Keratoacanthoma]] occurring within the [[red dye of a tattoo]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707285195\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_55  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_55      may_cause      2.6836          3              1\n",
        "\n",
        "Information from the SITE Cohort Study should clarify whether use of these [[immunosuppressive drugs]] for ocular inflammation increases the risk of mortality and [[fatal cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124696"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_56  positive_speculative      2.7424          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_56      may_cause      1.7424          2       0.635356\n",
        "1  drug_disease_56  used_to_treat      1.0000          1       0.364644\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for [[antimetabolites]], 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124682\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_59  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_59      may_cause      1.6113          2       0.672215\n",
        "1  drug_disease_59  used_to_treat      0.7857          1       0.327785\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for antimetabolites, 28%/62% for [[T-cell inhibitors]], and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124908\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id        broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_6  positive_speculative        2.85          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_6  used_to_treat        2.85          3              1\n",
        "\n",
        "[[Botulinum toxins]] are potent neurotoxins used in a variety of [[neurological disorders]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124841\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_62  positive_speculative      4.3012          5   \n",
        "0  drug_disease_62                 false      3.1240          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.579271      1  \n",
        "0       0.420729      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_62      may_cause      4.3012          5              1\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for [[alkylating agents]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124899\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_63  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_63      may_cause      1.5025          2        0.63676\n",
        "1  drug_disease_63  used_to_treat      0.8571          1        0.36324"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "There were consistent significant [[miosis]] in the right eyes with instilled [[Garcinia kola nut extract]] compared to the left eyes at 15, 30 and 45 minutes (p=0.0000).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124782\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_64  positive_speculative      4.1098          5   \n",
        "0  drug_disease_64                 false      2.4619          3   \n",
        "1  drug_disease_64              negative      0.8125          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.556567      1  \n",
        "0       0.333401      0  \n",
        "1       0.110032      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_64          other      3.2636          4       0.794102\n",
        "1  drug_disease_64  used_to_treat      0.8462          1       0.205898\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124684\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_65  positive_speculative      4.2677          5   \n",
        "1  drug_disease_65              negative      2.5999          3   \n",
        "0  drug_disease_65                 false      0.8000          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.556589      1  \n",
        "1       0.339076      0  \n",
        "0       0.104335      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_65  used_to_treat      4.2677          5              1\n",
        "\n",
        "There is evidence in the literature that [[inhaled corticosteroids]] (ICSs) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283605\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_69  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_69  used_to_treat       2.609          3              1\n",
        "\n",
        "[[5-aminosalicylic acid]] inhibits [[colitis-associated colorectal dysplasias]] in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124892\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id        broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_7  positive_speculative      2.6836          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_7  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_7      may_cause      0.8333          1       0.310516\n",
        "\n",
        "We describe the case of a 10-year-old boy who developed systemic weakness following treatment of [[spasticity]] with [[botulinum toxin type B]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124802\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_70  positive_speculative      2.4245          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_70      may_cause      2.4245          3              1\n",
        "\n",
        "The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/[[dextran sulfate sodium]] (DSS)-induced [[colitis-associated neoplasia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283108\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_71  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_71  used_to_treat      2.4833          3              1\n",
        "\n",
        "These data suggest that [[low-dose 5-ASA]] may be efficacious in preventing [[colitis-associated dysplasias]] and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124904\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_72  positive_speculative      7.5923          9   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_72  used_to_treat      7.5923          9              1\n",
        "\n",
        "These data suggest that [[low-dose 5-ASA]] may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of [[colonic neoplasms]] in patients with ulcerative colitis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124762\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_73  positive_speculative      6.0452          7   \n",
        "0  drug_disease_73                 false      0.9231          1   \n",
        "1  drug_disease_73              negative      0.7692          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.781286      1  \n",
        "0       0.119302      0  \n",
        "1       0.099412      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_73  used_to_treat      5.1221          6         0.8473\n",
        "0  drug_disease_73          other      0.9231          1         0.1527\n",
        "\n",
        "These data suggest that [[low-dose 5-ASA]] may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with [[ulcerative colitis]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707278758\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_74  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_74      may_cause      1.6923          2       0.648639\n",
        "1  drug_disease_74  used_to_treat      0.9167          1       0.351361\n",
        "\n",
        "The impact of the antiinflammatory agent 5-aminosalicylic acid ([[5-ASA]]) on the risk for [[colitis-associated colorectal cancer]] remains controversial.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124843"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_77  positive_speculative      2.3034          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_77  used_to_treat      2.3034          3              1\n",
        "\n",
        "Administration of 75 mg/kg [[5-ASA]] decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias ([[tumor]] burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124780\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_78  positive_speculative      2.5245          3   \n",
        "0  drug_disease_78                 false      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.774909      1  \n",
        "0       0.225091      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_78      may_cause      1.6912          2       0.669915\n",
        "1  drug_disease_78  used_to_treat      0.8333          1       0.330085\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of [[dysplasias]] of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124738\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_79  positive_speculative      2.7424          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_79  used_to_treat      2.7424          3              1\n",
        "\n",
        "Administration of 75 mg/kg [[5-ASA]] decreased both the mean multiplicity of [[flat dysplasias]] (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 707287494\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "       pub_rel_id        broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_8  positive_speculative      2.3596          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_8      may_cause      2.3596          3              1\n",
        "\n",
        "We describe the case of a 10-year-old boy who developed [[systemic weakness]] following treatment of spasticity with [[botulinum toxin type B]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124915\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_81  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_81      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_81  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of [[colonic dysplasias]] in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124822"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_82  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_82      may_cause      1.6515          2       0.694258\n",
        "1  drug_disease_82          other      0.7273          1       0.305742\n",
        "\n",
        "[[Spinal cord infarction]] secondary to [[cocaine]] use.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124849\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_83  positive_speculative      2.5983          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_83      may_cause      2.5983          3              1\n",
        "\n",
        "[[Cocaine]] abuse is associated with [[cerebrovascular events]]; spinal cord effects are rarely reported.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124731\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_84  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_84      may_cause       2.397          3              1\n",
        "\n",
        "Although uncommon, [[cocaine]] abuse can cause [[spinal cord infarction]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707004997\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_85  positive_speculative      2.5421          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_85      may_cause      2.5421          3              1\n",
        "\n",
        "We report two rheumatoid arthritis patients developing [[sarcoidosis]] possibly induced by [[etanercept]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124861\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_90  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_90          other      1.5904          2       0.674013\n",
        "0  drug_disease_90      may_cause      0.7692          1       0.325987\n",
        "\n",
        "Furthermore, there may be a relationship between [[statin]] dose and [[cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124891"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_93  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_93  used_to_treat       2.609          3              1\n",
        "\n",
        "[[BiRD]] is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed [[multiple myeloma]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124850\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_95  positive_speculative       6.615          8   \n",
        "0  drug_disease_95                 false       0.800          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.892111      1  \n",
        "0       0.107889      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_95  used_to_treat      5.7579          7       0.870431\n",
        "0  drug_disease_95          other      0.8571          1       0.129569\n",
        "\n",
        "A multipronged approach to limit [[endophthalmitis]] risk is also needed, with [[antibiotics]] as only part of the strategy.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707286886\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_96  positive_speculative      2.5126          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_96  used_to_treat      2.5126          3              1\n",
        "\n",
        "In this study, a 2-year-old girl with [[nephropathic cystinosis]] and severe gastrointestinal dysmotility was treated with intravenous ([[i.v.) administration of cysteamine hydrochloride]] (HCl).\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283447\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_97  positive_speculative        2.85          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_97      may_cause        2.85          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, nausea, vomiting, and [[diarrhea]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124817\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_98  positive_speculative      2.4564          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_98  used_to_treat      2.4564          3              1\n",
        "\n",
        "[[Posaconazole]] is noninferior to fluconazole for treatment of [[oropharyngeal candidiasis]] (95% CI -6.6 to 5.0), but necessity for this indication remains unclear, as many other treatment options exist.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124681"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_99  positive_speculative      4.4928          5   \n",
        "0  drug_disease_99                 false      1.6278          2   \n",
        "1  drug_disease_99              negative      1.5025          2   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.589367      1  \n",
        "0       0.213535      0  \n",
        "1       0.197098      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_99  used_to_treat      4.4928          5              1\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and [[aspergillosis]] (CI not reported, p < 0.001) when compared with fluconazole and [[itraconazole]] in neutropenic patients.\n",
        "\n",
        "============================================================\n"
       ]
      }
     ],
     "prompt_number": 24
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "temp = []\n",
      "for rel_id, group in deep_sem_res.groupby(\"pub_rel_id\"):\n",
      "    temp.append(group.iloc[0][\"percent_agree\"])\n",
      "    \n",
      "graph = pd.Series(sorted(temp)).plot()\n",
      "graph.set_ylim((0, 1.1))\n",
      "    "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 25,
       "text": [
        "(0, 1.1)"
       ]
      },
      {
       "metadata": {},
       "output_type": "display_data",
       "png": "iVBORw0KGgoAAAANSUhEUgAAAW8AAAD7CAYAAAClvBX1AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nQfsAAAAASUVORK5CYII=\n",
       "text": [
        "<matplotlib.figure.Figure at 0x7f38509e6250>"
       ]
      }
     ],
     "prompt_number": 25
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "The sentences for which the deep semantic choice confidence was < 80%"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "temp = []\n",
      "for rel_id, group in deep_sem_res.groupby(\"pub_rel_id\"):\n",
      "    if group.iloc[0][\"percent_agree\"] < 0.8:\n",
      "        temp.append((rel_id, group.iloc[0][\"percent_agree\"]))\n",
      "        \n",
      "temp = sorted(temp, key = lambda x: x[1])\n",
      "\n",
      "\n",
      "summary(map(lambda x: x[0], temp))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124912\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_168  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_168  used_to_treat      0.8571          1       0.354936\n",
        "0  drug_disease_168      may_cause      0.8077          1       0.334479\n",
        "1  drug_disease_168          other      0.7500          1       0.310585\n",
        "\n",
        "To determine [[cancer]] risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124806\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_38  positive_speculative      2.4245          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_38  used_to_treat      0.9412          1       0.388204\n",
        "0  drug_disease_38      may_cause      0.7500          1       0.309342\n",
        "1  drug_disease_38          other      0.7333          1       0.302454\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124876\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_41  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_41          other      1.0000          1       0.402690\n",
        "2  drug_disease_41  used_to_treat      0.7500          1       0.302017\n",
        "0  drug_disease_41      may_cause      0.7333          1       0.295293\n",
        "\n",
        "The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]] on [[glioma]] cell lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124771\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_39  positive_speculative      4.1544          5   \n",
        "1  drug_disease_39              negative      2.5743          3   \n",
        "0  drug_disease_39                 false      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.556741      1  \n",
        "1       0.344988      0  \n",
        "0       0.098271      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_39  used_to_treat      1.6904          2       0.406894\n",
        "1  drug_disease_39          other      1.6515          2       0.397530\n",
        "0  drug_disease_39      may_cause      0.8125          1       0.195576\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124831\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_211  positive_speculative      3.3181          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_211      may_cause      1.6666          2       0.502275\n",
        "2  drug_disease_211  used_to_treat      0.8333          1       0.251138\n",
        "1  drug_disease_211          other      0.8182          1       0.246587"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with febuxostat than with [[allopurinol]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124846\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_26  positive_speculative      1.7594          2   \n",
        "0  drug_disease_26                 false      0.7273          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.707524      1  \n",
        "0       0.292476      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_26  used_to_treat      0.9412          1       0.534955\n",
        "0  drug_disease_26          other      0.8182          1       0.465045\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124917\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_115  positive_speculative      7.3867          9   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_115      may_cause      4.0131          5       0.543287\n",
        "1  drug_disease_115  used_to_treat      3.3736          4       0.456713\n",
        "\n",
        "While some beneficial neuromotor effects of succimer therapy were observed in the present study there remains several unanswered questions such as how long these effects will persist and how [[succimer]] therapy modifies lead-associated [[cerebellar deficits]] manifesting as perturbations in vestibular and/or proprioception systems for postural balance and functional locomotion.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124696\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_56  positive_speculative      2.7424          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_56      may_cause      1.7424          2       0.635356\n",
        "1  drug_disease_56  used_to_treat      1.0000          1       0.364644\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for [[antimetabolites]], 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124724\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_40  positive_speculative      6.6163          8   \n",
        "0  drug_disease_40                 false      0.8235          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.889312      1  \n",
        "0       0.110688      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_40  used_to_treat      4.2113          5       0.636504\n",
        "0  drug_disease_40      may_cause      1.4606          2       0.220758\n",
        "1  drug_disease_40          other      0.9444          1       0.142738\n",
        "\n",
        "Further investigations using in vivo [[glioma]] model should be helpful to confirm the distinct effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]], in normal versus tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124899"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_63  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_63      may_cause      1.5025          2        0.63676\n",
        "1  drug_disease_63  used_to_treat      0.8571          1        0.36324\n",
        "\n",
        "There were consistent significant [[miosis]] in the right eyes with instilled [[Garcinia kola nut extract]] compared to the left eyes at 15, 30 and 45 minutes (p=0.0000).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124726\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_29  positive_speculative      2.5971          3   \n",
        "0  drug_disease_29                 false      0.8333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.757084      1  \n",
        "0       0.242916      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_29  used_to_treat      1.6559          2       0.637596\n",
        "0  drug_disease_29      may_cause      0.9412          1       0.362404\n",
        "\n",
        "Mean [[pain]] (mm) recorded before injection, before reduction, and after reduction in the [[intra-articular lidocaine]] group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124868\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_45  positive_speculative      6.3885          8   \n",
        "0  drug_disease_45              negative      0.8182          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.886467      1  \n",
        "0       0.113533      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_45  used_to_treat      4.0851          5       0.639446\n",
        "0  drug_disease_45      may_cause      2.3034          3       0.360554\n",
        "\n",
        "Further investigations using in vivo [[glioma]] model should be helpful to confirm the distinct effects of [[indomethacin-loaded nanocapsules]] and indomethacin ethyl ester-loaded nanocapsules, in normal versus tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124734\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_225  positive_speculative      2.5589          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_225      may_cause      1.6498          2        0.64473\n",
        "1  drug_disease_225          other      0.9091          1        0.35527\n",
        "\n",
        "[[Pulmonary alveolar proteinosis]]: a rare pulmonary toxicity of [[sirolimus]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124856\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_213  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_213  used_to_treat      1.5577          2       0.645064\n",
        "0  drug_disease_213          other      0.8571          1       0.354936\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately [[impaired renal function]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707278758\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_74  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_74      may_cause      1.6923          2       0.648639\n",
        "1  drug_disease_74  used_to_treat      0.9167          1       0.351361\n",
        "\n",
        "The impact of the antiinflammatory agent 5-aminosalicylic acid ([[5-ASA]]) on the risk for [[colitis-associated colorectal cancer]] remains controversial.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124821\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_113  positive_speculative      2.4848          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_113  used_to_treat      1.6515          2       0.664641\n",
        "0  drug_disease_113      may_cause      0.8333          1       0.335359\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124721\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_170  positive_speculative      2.4892          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_170      may_cause      1.6559          2       0.665234\n",
        "1  drug_disease_170  used_to_treat      0.8333          1       0.334766\n",
        "\n",
        "Incidence of [[melanoma]] and other malignancies among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124733\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_42  positive_speculative      2.4892          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_42  used_to_treat      1.6559          2       0.665234\n",
        "0  drug_disease_42      may_cause      0.8333          1       0.334766\n",
        "\n",
        "Indomethacin and [[indomethacin ethyl ester]] associated together in the same nanocapsule formulation caused a synergic effect decreasing [[glioma]] cell proliferation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706694486"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_22  positive_speculative      2.4148          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_22  used_to_treat      1.6071          2       0.665521\n",
        "0  drug_disease_22      may_cause      0.8077          1       0.334479\n",
        "\n",
        "The combination of [[high-dose MTX]] with procarbazine and CCNU is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124698\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_30  positive_speculative      2.4686          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_30  used_to_treat      1.6504          2       0.668557\n",
        "0  drug_disease_30      may_cause      0.8182          1       0.331443\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707280277\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_194  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_194  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_194      may_cause      0.8571          1       0.331195\n",
        "\n",
        "This study demonstrated that both low-dose [[topiramate]] and propranolol could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124863\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_209  positive_speculative      2.5879          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_209  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_209      may_cause      0.8571          1       0.331195\n",
        "\n",
        "At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did [[allopurinol]] (300 or 100 mg) or placebo in subjects with [[hyperuricemia]] and gout, including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124780\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_78  positive_speculative      2.5245          3   \n",
        "0  drug_disease_78                 false      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.774909      1  \n",
        "0       0.225091      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_78      may_cause      1.6912          2       0.669915\n",
        "1  drug_disease_78  used_to_treat      0.8333          1       0.330085"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of [[dysplasias]] of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124682\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_59  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_59      may_cause      1.6113          2       0.672215\n",
        "1  drug_disease_59  used_to_treat      0.7857          1       0.327785\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for antimetabolites, 28%/62% for [[T-cell inhibitors]], and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124861\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_90  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_90          other      1.5904          2       0.674013\n",
        "0  drug_disease_90      may_cause      0.7692          1       0.325987\n",
        "\n",
        "Furthermore, there may be a relationship between [[statin]] dose and [[cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124794\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_154  positive_speculative      2.4745          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_154  used_to_treat      1.6745          2       0.676702\n",
        "0  drug_disease_154      may_cause      0.8000          1       0.323298\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/[[prednisone]]) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124740\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_151  positive_speculative       2.397          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_151  used_to_treat      1.6278          2       0.679099\n",
        "0  drug_disease_151      may_cause      0.7692          1       0.320901\n",
        "\n",
        "Plasma [[ziprasidone]] levels ranged from 20 ng/mL to 160 ng/mL (mean: 75.8 ng/mL) and were significantly related to the improvement in [[negative symptoms]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124812\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_145  positive_speculative      2.5873          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_145  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_145      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, [[adriamycin]] 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124820\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_147  positive_speculative      2.5873          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_147  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_147      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and [[prednisone]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124707\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_50  positive_speculative      2.4004          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_50  used_to_treat      1.6504          2       0.687552\n",
        "0  drug_disease_50      may_cause      0.7500          1       0.312448\n",
        "\n",
        "Although the role of [[clozapine]] is well established for [[treatment-resistant schizophrenia]], it is rarely used in pediatric populations, mainly due to its potentially serious adverse effects.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124828\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_169  positive_speculative      2.5666          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_169      may_cause      1.7666          2       0.688304\n",
        "1  drug_disease_169  used_to_treat      0.8000          1       0.311696\n",
        "\n",
        "Incidence of melanoma and other [[malignancies]] among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124719\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_141  positive_speculative      2.6754          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_141  used_to_treat      1.8421          2       0.688533\n",
        "0  drug_disease_141      may_cause      0.8333          1       0.311467\n",
        "\n",
        "An open multicenter phase II trial of weekly [[docetaxel]] for [[advanced-stage non-small-cell lung cancer]] in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124894"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_167  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_167  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_167      may_cause      0.8333          1       0.310516\n",
        "\n",
        "To determine cancer risk in a cohort of 459 [[rheumatoid arthritis]] (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124910\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_32  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_32  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_32      may_cause      0.8333          1       0.310516\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124889\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_36  positive_speculative      2.6836          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_36  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_36      may_cause      0.8333          1       0.310516\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124892\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id        broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_7  positive_speculative      2.6836          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_7  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_7      may_cause      0.8333          1       0.310516\n",
        "\n",
        "We describe the case of a 10-year-old boy who developed systemic weakness following treatment of [[spasticity]] with [[botulinum toxin type B]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124858\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_159  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_159      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_159  used_to_treat      0.8077          1       0.309558"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and [[lung cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124874\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_25  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_25  used_to_treat      1.8015          2       0.690442\n",
        "0  drug_disease_25      may_cause      0.8077          1       0.309558\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as [[intravenous meperidine]] and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124915\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_81  positive_speculative      2.6092          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_81      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_81  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of [[colonic dysplasias]] in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124830\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_110  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_110  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_110          other      0.7273          1       0.305742\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and [[aspergillosis]] incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124798\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_27  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_27  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_27          other      0.7273          1       0.305742\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124822\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_82  positive_speculative      2.3788          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_82      may_cause      1.6515          2       0.694258\n",
        "1  drug_disease_82          other      0.7273          1       0.305742\n",
        "\n",
        "[[Spinal cord infarction]] secondary to [[cocaine]] use.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124879\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_231  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_231  used_to_treat      1.7333          2       0.697983\n",
        "0  drug_disease_231      may_cause      0.7500          1       0.302017\n",
        "\n",
        "We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of [[severe diarrhea]] due to [[MMF]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124716\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_192  positive_speculative      2.4221          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_192      may_cause      1.6948          2       0.699723\n",
        "1  drug_disease_192  used_to_treat      0.7273          1       0.300277\n",
        "\n",
        "The most frequent and the most troublesome adverse effect of interferon plus [[ribavirin]]-based therapy is [[anaemia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124895\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_240  positive_speculative       2.609          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_240  used_to_treat      1.8398          2       0.705174\n",
        "0  drug_disease_240      may_cause      0.7692          1       0.294826\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of [[prednisone]]; survival is statistically significantly better among patients receiving BDP.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124815\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_216  positive_speculative      2.5078          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_216      may_cause      1.7745          2       0.707592\n",
        "1  drug_disease_216  used_to_treat      0.7333          1       0.292408\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with [[febuxostat]] than with allopurinol.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124680"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_190  positive_speculative      6.2663          7   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_190      may_cause      4.6330          5       0.739352\n",
        "1  drug_disease_190          other      0.8333          1       0.132981\n",
        "2  drug_disease_190  used_to_treat      0.8000          1       0.127667\n",
        "\n",
        "[[Zidovudine]] discontinuation could help to avoid [[anaemia]] associated with anti-HCV therapy.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124875\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "1  drug_disease_106  positive_speculative      6.6010          8   \n",
        "0  drug_disease_106              negative      0.7857          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "1       0.893633      1  \n",
        "0       0.106367      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_106  used_to_treat      5.0071          6       0.758537\n",
        "1  drug_disease_106          other      0.8571          1       0.129844\n",
        "0  drug_disease_106      may_cause      0.7368          1       0.111619\n",
        "\n",
        "At this time, [[posaconazole]] should probably be reserved for prophylaxis in patients at high risk for [[invasive fungal infection]], as salvage therapy in refractory or resistant infections, or for patients with intolerance to other therapies.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124706\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_33  positive_speculative      7.3413          9   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_33  used_to_treat      5.5849          7       0.760751\n",
        "1  drug_disease_33          other      0.9231          1       0.125741\n",
        "0  drug_disease_33      may_cause      0.8333          1       0.113509\n",
        "\n",
        "Selective cytotoxicity of [[indomethacin]] and indomethacin ethyl ester-loaded nanocapsules against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124742\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_191  positive_speculative      3.3201          4   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_191  used_to_treat      2.5509          3        0.76832\n",
        "0  drug_disease_191      may_cause      0.7692          1        0.23168\n",
        "\n",
        "The risk of [[anaemia]] was lower in patients with higher baseline haemoglobin levels (OR, 0.35 95% CI, 0.26-0.49, P < 0.0001) and in patients receiving [[protease inhibitor]]-based antiretroviral therapy (OR, 0.51 95% CI, 0.30-0.86, P = 0.0114).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124712\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_223  positive_speculative      3.3201          4   \n",
        "0  drug_disease_223                 false      3.2879          4   \n",
        "1  drug_disease_223              negative      0.7333          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.452250      1  \n",
        "0       0.447863      0  \n",
        "1       0.099887      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_223      may_cause      2.5928          3        0.78094\n",
        "1  drug_disease_223          other      0.7273          1        0.21906"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Data of our study revealed an unexpected high rate of hypogonadism irrespective of [[cyclophosphamide]] use, and subclinical involvement of the testes by the [[vasculitis]] itself might be an alternative explanation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124782\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_64  positive_speculative      4.1098          5   \n",
        "0  drug_disease_64                 false      2.4619          3   \n",
        "1  drug_disease_64              negative      0.8125          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.556567      1  \n",
        "0       0.333401      0  \n",
        "1       0.110032      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_64          other      3.2636          4       0.794102\n",
        "1  drug_disease_64  used_to_treat      0.8462          1       0.205898\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n"
       ]
      }
     ],
     "prompt_number": 26
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "temp = []\n",
      "for rel_id, group in deep_sem_res.groupby(\"pub_rel_id\"):\n",
      "    if group.iloc[0][\"deep_semantics\"] == \"other\":\n",
      "        temp.append((rel_id, group.iloc[0][\"percent_agree\"]))\n",
      "        \n",
      "temp = sorted(temp, key = lambda x: x[1])\n",
      "\n",
      "\n",
      "summary(map(lambda x: x[0], temp))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124876\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_41  positive_speculative      2.4833          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_41          other      1.0000          1       0.402690\n",
        "2  drug_disease_41  used_to_treat      0.7500          1       0.302017\n",
        "0  drug_disease_41      may_cause      0.7333          1       0.295293\n",
        "\n",
        "The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]] on [[glioma]] cell lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124861\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "0  drug_disease_90  positive_speculative      2.3596          3   \n",
        "\n",
        "   percent_agree  match  \n",
        "0              1      1  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_90          other      1.5904          2       0.674013\n",
        "0  drug_disease_90      may_cause      0.7692          1       0.325987\n",
        "\n",
        "Furthermore, there may be a relationship between [[statin]] dose and [[cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124782\n",
        "\n",
        "EU-ADR answer: positive_speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id        broad_rel_type  conf_score  num_votes  \\\n",
        "2  drug_disease_64  positive_speculative      4.1098          5   \n",
        "0  drug_disease_64                 false      2.4619          3   \n",
        "1  drug_disease_64              negative      0.8125          1   \n",
        "\n",
        "   percent_agree  match  \n",
        "2       0.556567      1  \n",
        "0       0.333401      0  \n",
        "1       0.110032      0  \n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_64          other      3.2636          4       0.794102\n",
        "1  drug_disease_64  used_to_treat      0.8462          1       0.205898\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n"
       ]
      }
     ],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": []
    }
   ],
   "metadata": {}
  }
 ]
}